The Clinical Value of Routine Acetaminophen Level Screening in Pediatric Patients Presenting to the Emergency

Anna Shklovsky-Kordi1, Renana Gelernter1,2, Matitiahu Berkovitch1,2

  • 1Department of Pediatrics, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel.

Insights

Acetaminophen poisoning in children is common, but severe liver injury is rare, especially in younger children with accidental ingestion. A history of ingestion significantly increases the risk of detectable acetaminophen levels.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Toxicology
  • Pharmacovigilance

Background:

  • Acetaminophen is a leading cause of pediatric poisoning and acute liver failure.
  • Accidental and intentional ingestions pose significant risks.

Purpose of the Study:

  • Characterize pediatric patients undergoing acetaminophen level testing in an emergency department.
  • Identify variables associated with acetaminophen toxicity risk.

Main Methods:

  • Retrospective case series of patients under 18 years old.
  • Data collected from January 2008 to December 2015.
  • Serum acetaminophen concentrations were measured.

Main Results:

  • 209 out of 180,174 pediatric emergency department admissions had acetaminophen levels measured.
  • 12 patients had elevated liver enzymes; 5 had acute liver injury (all >11 years old).
  • A positive history of ingestion correlated with detectable acetaminophen levels (28-fold increased risk).

Conclusions:

  • Hepatotoxicity risk is low in young children with accidental acetaminophen intoxication.
  • A history of ingestion is a key indicator for elevated acetaminophen levels and potential toxicity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
117
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
87
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
141
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
121
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
116